J Tomazic
Overview
Explore the profile of J Tomazic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balayan T, Begovac J, Skrzat-Klapaczynska A, Aho I, Alexiev I, Bukovinova P, et al.
HIV Med
. 2020 Oct;
22(1):67-72.
PMID: 33021049
Objectives: Pre-exposure prophylaxis (PrEP) for HIV infection is an important intervention for control of the HIV epidemic. The incidence of HIV infection is increasing in the countries of Central and...
2.
Kowalska J, Bursa D, Gokengin D, Jilich D, Tomazic J, Vasylyev M, et al.
HIV Med
. 2018 Jul;
19(9):629-633.
PMID: 29989332
Objectives: Pre-exposure prophylaxis (PrEP) for HIV infection has been introduced in only a few European countries. We investigated the potential to provide PrEP in the Central and Eastern European region,...
3.
Shepherd L, Borges A, Harvey R, Bower M, Grulich A, Silverberg M, et al.
HIV Med
. 2017 Sep;
19(2):90-101.
PMID: 28857427
Objectives: B-cell dysfunction and activation are thought to contribute to lymphoma development in HIV-positive people; however, the mechanisms are not well understood. We investigated levels of several markers of B-cell...
4.
Mlakar J, Lunar M, Abecasis A, Vandamme A, Tomazic J, Vovko T, et al.
Virus Evol
. 2017 Aug;
3(Suppl 1).
PMID: 28845276
No abstract available.
5.
Shepherd L, Borges A, Ledergerber B, Domingo P, Castagna A, Rockstroh J, et al.
HIV Med
. 2016 Feb;
17(8):590-600.
PMID: 26890156
Objectives: HIV-positive people have increased risk of infection-related malignancies (IRMs) and infection-unrelated malignancies (IURMs). The aim of the study was to determine the impact of aging on future IRM and...
6.
Hofstra L, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al.
Clin Infect Dis
. 2015 Dec;
62(5):655-663.
PMID: 26620652
Background: Numerous studies have shown that baseline drug resistance patterns may influence the outcome of antiretroviral therapy. Therefore, guidelines recommend drug resistance testing to guide the choice of initial regimen....
7.
Borstnar S, Lindic J, Tomazic J, Kandus A, Pikelj A, Prah J, et al.
Transplant Proc
. 2013 Jun;
45(4):1614-7.
PMID: 23726632
Background: Pneumocystis jirovecii pneumonia (PCP) represents an important cause of morbidity and mortality in kidney transplant recipients. In recent years an increasing number of PCP outbreaks have been reported worldwide....
8.
Grgic-Vitek M, Frelih T, Ucakar V, Prosenc K, Tomazic J, Petrovec M, et al.
Euro Surveill
. 2010 May;
15(20).
PMID: 20504390
After ten years of being measles free, Slovenia experienced a cluster with secondary transmission in a hospital setting in March 2010. The index case, a resident of Ireland, was hospitalised...
9.
Grego K, Arnol M, Bren A, Kmetec A, Tomazic J, Kandus A
Transplant Proc
. 2007 Dec;
39(10):3093-7.
PMID: 18089329
In this prospective, randomized, open-label, single-center study, we compared the efficacy and safety of two anti-interleukin-2 receptor monoclonal antibodies among adult recipients of at least 1 HLA-mismatched deceased donor renal...
10.
Seme K, Poljak M, Begovac J, Vince A, Tomazic J, Vidmar L, et al.
Acta Virol
. 2002 Oct;
46(2):91-4.
PMID: 12387500
The prevalence of hepatitis C virus (HCV) infection in the population of human immunodeficiency virus 1 (HIV-1)-infected individuals from Slovenia and Croatia was determined. One hundred and sixty-six out of...